Hassan, Mais Salah, and Ali Mohammed Jawad. 2026. “Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer”. Middle Eastern Cancer and Oncology Journal 2 (3): 1-9. https://doi.org/10.61706/MECOJ160229.